C-Rad Dirección

Dirección controles de criterios 1/4

El CEO de C-Rad es Cecilia de Leeuw , nombrado en Dec 2022, tiene una permanencia de 1.92 años. compensación anual total es SEK2.98M, compuesta por 70.4% salario y 29.6% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.042% de las acciones de la empresa, por valor de SEK399.67K. La antigüedad media del equipo directivo y de la junta directiva es de 1.9 años y 1.5 años, respectivamente.

Información clave

Cecilia de Leeuw

Chief Executive Officer (CEO)

SEK 3.0m

Compensación total

Porcentaje del salario del CEO	70.4%
Permanencia del CEO	1.9yrs
Participación del CEO	0.04%
Permanencia media de la dirección	1.9yrs
Promedio de permanencia en la Junta Directiva	1.5yrs

Actualizaciones recientes de la dirección

Recent updates

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Cecilia de Leeuw en comparación con los beneficios de C-Rad?
Fecha	Compensación total	Salario	Ingresos de la empresa
Sep 30 2024	n/a	n/a	SEK 58m
Jun 30 2024	n/a	n/a	SEK 54m
Mar 31 2024	n/a	n/a	SEK 48m
Dec 31 2023	SEK 3m	SEK 2m	SEK 36m
Sep 30 2023	n/a	n/a	SEK 24m
Jun 30 2023	n/a	n/a	SEK 20m
Mar 31 2023	n/a	n/a	SEK 12m
Dec 31 2022	SEK 839k	SEK 175k	SEK 7m

Compensación vs. Mercado: La compensación total ($USD271.12K) de Cecilia está en línea con el promedio de empresas de tamaño similar en el mercado UK ($USD354.57K).

Compensación vs. Ingresos: La compensación de Cecilia ha aumentado más de un 20% en el último año.

CEO

Cecilia de Leeuw (56 yo)

1.9yrs

Permanencia

SEK 2,981,000

Compensación

Ms. Cecilia de Leeuw was Director of Kambi Group plc since May 16, 2019 until May 22, 2024. She is an Independent Director of Net Insight AB (publ) since May 2022. She is Chief Executive Officer of C-Rad A...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Cecilia de Leeuw	CEO & President	1.9yrs	SEK 2.98m	0.042% SEK 399.7k
Linda Frölén	Chief Financial Officer	less than a year	sin datos	sin datos
Hakan Axelsson	Chief Operating Officer	5.3yrs	sin datos	sin datos
Greta Cattani	Global Marketing Director	1.2yrs	sin datos	sin datos
Anna Aman	Human Resource Manager	less than a year	sin datos	sin datos
Xiaodong Wang	President of C-RAD China	6.8yrs	sin datos	0.12% SEK 1.1m
Ivan Astralaga	President of C-RAD Americas	3.5yrs	sin datos	sin datos
Basak Karakus	Executive for Global Digital Marketing	no data	sin datos	sin datos

1.9yrs

Permanencia media

50.5yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de 0R44 no se considera experimentado ( 1.9 años antigüedad media), lo que sugiere un nuevo equipo.

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Kristina Willgard	Independent Chair of the Board	1.5yrs	SEK 280.00k	0.030% SEK 285.5k
Mats Thoren	Independent Director	less than a year	sin datos	sin datos
Jenny Rosberg	Independent Director	3.8yrs	SEK 255.00k	0.051% SEK 485.4k
Susanne Ekblom	Independent Director	1.5yrs	SEK 160.00k	sin datos
Peter Simonsbacka	Independent Director	1.5yrs	SEK 147.00k	sin datos
David Sjostrom	Independent Director	7.5yrs	SEK 220.00k	sin datos

1.5yrs

Permanencia media

58yo

Promedio de edad

Junta con experiencia: La junta directiva de 0R44 no se considera experimentada (1.5 años de permanencia promedio), lo que sugiere una nueva junta directiva.

C-Rad Dirección

Dirección controles de criterios 1/4

Información clave

Actualizaciones recientes de la dirección

Independent Director recently bought kr190k worth of stock

CEO & President recently bought kr85k worth of stock

C-Rad AB (publ) Appoints Mats Thorén as Board Member

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Recent updates

C-Rad AB (publ) to Report Q3, 2025 Results on Oct 23, 2025

Independent Director recently bought kr190k worth of stock

New minor risk - Market cap size

Third quarter 2024 earnings released: EPS: kr0.45 (vs kr0.32 in 3Q 2023)

CEO & President recently bought kr85k worth of stock

Second quarter 2024 earnings released: EPS: kr0.31 (vs kr0.16 in 2Q 2023)

Full year 2023 earnings released: EPS: kr1.05 (vs kr0.22 in FY 2022)

C-Rad AB (publ) Appoints Mats Thorén as Board Member

C-Rad AB (publ) to Report Fiscal Year 2023 Results on Apr 23, 2024

Full year 2023 earnings released: EPS: kr1.36 (vs kr0.22 in FY 2022)

C-Rad AB (publ) to Report Q3, 2024 Results on Oct 23, 2024

Third quarter 2023 earnings released

Investor sentiment improves as stock rises 17%

Less than half of directors are independent

C-Rad AB (Publ) Announces Former Employee Appeals Verdict from the Patent and Market Court of Appeal

New major risk - Earnings quality

C-Rad AB (publ) to Demonstrate Enhancements in Surface Guided Solutions for Advanced Radiotherapy Treatments at AAPM

Second quarter 2023 earnings released

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

C-Rad AB (publ) to Report Fiscal Year 2022 Final Results on Apr 06, 2023

C-Rad AB (Publ) Appoints Christoffer Herou as CFO

C-Rad AB (Publ) Announces CEO Changes

C-Rad AB (publ) Announces CFO Changes

C-Rad AB (publ) to Report Q3, 2023 Results on Oct 27, 2023

C-RAD Launches New Updated eDucation Portal as an Online Platform

Second quarter 2022 earnings released

Henrik Bergentoft Resigns as CFO of C-RAD

C-Rad Announces CEO Changes

Insufficient new directors

Insufficient new directors

C-Rad AB (publ) to Report Q3, 2022 Results on Oct 28, 2022

C-Rad Achieves Another Milestone Ensuring the Availability of SGRT, the Standard of Care for Radiotherapy

Third quarter 2021 earnings released

Chief Operating Officer recently sold kr625k worth of stock

Second quarter 2021 earnings released

C-Rad AB (publ) Announces The Patent and Market Court Rejected Former Employee Claim for Compensation

The Patent and Market Court of Appeal Issues Judgement Confirming C-Rad's Entitlement to Beamocular's Invention

Full year 2020 earnings released: EPS kr0.43 (vs kr0.45 loss in FY 2019)

C-RAD and Alliance Radiation Oncology Announce That Alliance Has Become the First Center in the Greater Northshore Area to Integrate C-Rad

C-Rad and With-Global Engages in a Partnership for the South Korean Market

C-RAD Receives Order for Proton Cancer Treatment Centers in the US

Shenzhen Proton Therapy Treatment Center Selects C-Rad Catalyst™ System

C-Rad AB (publ) to Report Q2, 2021 Results on Jul 29, 2021

Shanghai Proton and Heavy Ion Hospital Decides for C-Rad Sigrt Solution

Australian Customers Select C-RAD’s Cutting Edge SIGRT Solution

C-Rad AB Receives SEK 11 Million Order for Cutting Edge SIGRT Solution by DTZ in Berlin

Independent Director recently sold kr672.4k worth of stock

Independent Director recently bought kr1.7m worth of stock

Independent Director recently sold kr3.4m worth of stock

Análisis de compensación del CEO

CEO

Permanencia

Compensación

Equipo directivo

Permanencia media

Promedio de edad

Miembros de la Junta

Permanencia media

Promedio de edad